Bradley J. Bolzon Ph.D., Director at CRISPR Therapeutics AG (CRSP), sold 17,930 shares at $86.98 ($1.6M) on 2020-09-16, disclosed to the SEC on 2020-09-18.
Open-market sale of $1.6M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.98 | 8,965 | $780K | 50.0% |
| 2 | $86.98 | 8,965 | $780K | 50.0% |
| Total | $86.98 avg | 17,930 | $1.6M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-30 | $9.2M | — | Filing → |
| GLUE | BUY | 2021-06-30 | $3.0M | — | Filing → |
| CRSP | SELL | 2021-06-15 | $2.3M | — | Filing → |